WallStreetZenWallStreetZen

NASDAQ: VRAX
Virax Biolabs Group Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Virax Biolabs Group revenue was $6.33k for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, VRAX annual revenue was $6.3k, with -96% growth year-over-year.

VRAX past revenue growth

How has VRAX's revenue growth performed historically?

Company
-95.95%
Industry
148.03%
Market
17.03%
VRAX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VRAX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VRAX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VRAX revenue history

Current Revenue
$6.3k
Current Earnings
-$6.1M
Current Profit Margin
-95,739.2%

Be the first to know when VRAX announces revenue.

VRAX Revenue History By Year

VRAX Yearly RevenueVRAX RevenueVRAX ChangeVRAX Revenue Growth
2025-03-31$6.33k-$150.09k-95.95%
2024-03-31$156.42k$147.86k+1,727.11%
2023-03-31$8.56kN/AN/A
2022-03-31$0.00-$123.82k-100.00%
2021-03-31$123.82k$23.94k+23.97%
2020-03-31$99.88kN/AN/A

1 of 1

Virax Biolabs Group Revenue FAQ

What was VRAX's revenue last quarter?

Virax Biolabs Group (NASDAQ: VRAX) reported Q1 2025 revenue of N/A up N/A year over year. In the same quarter last year, Virax Biolabs Group's revenue was N/A.

What was Virax Biolabs Group's revenue in 2025?

Virax Biolabs Group's annual revenue for the twelve months ending Mar 31, 2025 was $6.33 thousand, a 95.95% decrease year over year.

How much does Virax Biolabs Group make in a day?

Based on Virax Biolabs Group annual revenue for the past five years, VRAX makes an average of $161.72 per day.

What was Virax Biolabs Group's annual revenue growth in the past year?

As of Q3 2025, Virax Biolabs Group's revenue has grown -95.95% year over year. This is 243.99 percentage points lower than the US Biotechnology industry revenue growth rate of 148.03%. Virax Biolabs Group's revenue in the past year totaled $6.33 thousand.

How much does Virax Biolabs Group make in a year?

Virax Biolabs Group's revenue by year for the past five years is:
  • Virax Biolabs Group's revenue for the twelve months ending Mar 31, 2025 was $6.33 thousand, a 95.95% decrease year over year.
  • Virax Biolabs Group's annual revenue for Mar 31, 2024 was $156.42 thousand, a 1,727.11% increase from 2023.
  • Virax Biolabs Group's annual revenue for 2023 was $8.56 thousand, a Infinity% increase from 2022.
  • Virax Biolabs Group's annual revenue for 2022 was $0.00, a 100% decrease from 2021.
  • Virax Biolabs Group's annual revenue for 2021 was $123.82 thousand, a 23.97% increase from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.